Orthopedic injuries that historically went to the OR — rotator cuff tears, ACL repair recovery, cartilage damage, advanced tendinopathy — increasingly have a regenerative path. The path is not magic, and the evidence base varies sharply by therapy. What follows is what I’ve seen work, the indications where the literature is strongest, and what to ask before any injection.
Why this matters in orthopedics
Regenerative therapies leverage the body’s own repair processes. For arthritis, cartilage damage, and tendon injuries the advantages are real:
- Minimally invasive, avoiding the morbidity of open surgery.
- Stimulates cellular repair instead of replacing tissue.
- Faster return to function in the right indications.
But “right indication” is doing a lot of work in that sentence. Some injuries respond beautifully to PRP. Others need surgical reconstruction and no biologic shortcut will change that.
The treatments and what they’re for
Stem cell therapy for joint repair
“Stem cell therapy” is an umbrella. Some treatments use autologous (your own) cells — microfragmented adipose tissue (mFAT) or bone marrow aspirate concentrate (BMAC). Others use donor-based orthobiologics: umbilical cord cells, donor MSCs, exosomes. Risk profiles differ by source, processing, and the clinic’s compliance with safety standards.
Common targets: knee and hip arthritis, cartilage regeneration for degenerative joints, rotator cuff repair.
Regulatory status. In the U.S. the FDA classifies stem cell products as minimally manipulated (Section 361, lower oversight, usually autologous) or substantially manipulated (Section 351, regulated as drugs with required clinical trials). Stromal vascular fraction (SVF) is classified as a drug due to its processing. The EMA in Europe uses ATMP guidelines for advanced cell therapies. Globally the rigor varies — choose an experienced provider operating inside a real regulatory framework.
Platelet-rich plasma (PRP)
Patient blood drawn, platelets and growth factors concentrated, injected into damaged tissue. Reduces inflammation, supports tissue repair, strengthens ligaments and tendons.
Best evidence: rotator cuff injuries, tennis elbow, ACL repair recovery, knee osteoarthritis.
Dr. Rowan Paul used PRP to treat my foot pain and several other hEDS-related injuries. Cutting-edge clinical experience translated into outcomes — I avoided invasive procedures and held the results.
Exosome therapy
Exosomes are extracellular vesicles, often derived from stem cells, that deliver proteins and growth factors to damaged tissue. The promise is targeted repair without the cellular risks of true stem cell injection.
Indications under active study: tendon and ligament injuries, chronic pain, cartilage repair. Benefits in early data: reduced inflammation, faster tissue regeneration, minimal downtime.
Regulatory status. As of 2025 the FDA has not approved exosome products for therapeutic use in the U.S. Quality varies widely; preparation and handling matter enormously.
What this looks like in real cases
Rotator cuff and shoulder injuries
PRGF, as used by Dr. Ramon Cugat at Instituto Cugat in Spain, has enabled patients to recover faster than with traditional surgical timelines, with mobility and pain outcomes that often exceed post-surgical baselines.
Knee arthritis and cartilage
Stem cell therapy offers an alternative to joint replacement in osteoarthritis. Dr. Cugat — a pioneer in arthroscopic surgery in Spain — has advanced ACL repair specifically by integrating growth factors and stem cells. His patients include elite athletes (Pep Guardiola, Xavi Hernández, Fernando Torres) who travel to him for knee work. PRP also provides meaningful pain and function improvements in early-stage knee arthritis.
Sports injuries
Exosome therapy is emerging as a non-surgical option for ligament and tendon injuries, with the practical advantage that it doesn’t require a blood draw — important for patients in whom draws are difficult or contraindicated.
Where the field is going
- Stem cells. Refined harvesting, better regulatory clarity, improved cell cultivation and safety should drive better outcomes in cartilage regeneration and ACL repair.
- PRP / PRGF / PRF. Better platelet isolation will broaden indications, particularly for chronic pain management and injury prevention.
- Exosomes. Ongoing trials suggest mainstream use for sports-related tendon and ligament injury once regulation catches up.
Disclaimer
Many regenerative therapies — including exosomes, SVF, and several stem cell-derived products — remain under FDA investigation. Work with qualified providers, verify FDA or EMA compliance, and confirm ethical sourcing and safe preparation.
My own case
PRP, PRF, PRGF, orthobiologics, growth factors, and hyaluronic acid in joints (which provides lubrication and meaningfully reduces early-arthritis pain) collectively kept me mobile and out of the OR — across hands, spine, hips, feet, knees, and shoulders. The names that mattered: Dr. Rowan Paul, Dr. Ramon Cugat, Dr. Matt Cook, Dr. Jonathan Kuo, and several others. The right therapies in skilled hands changed the trajectory.